PMID: 15714922Feb 18, 2005Paper

Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?

Clinical Oncology : a Journal of the Royal College of Radiologists
P HatfieldA Melcher

Abstract

Dendritic cells are key orchestrators of the immune system. There is considerable interest in their use for treating cancer. Whether they initiate an effective cytotoxic response against antigen-bearing cells, or produce tolerance, depends on the context in which those antigens are presented. Ionising radiation, and the cell death it causes, has several properties that may facilitate such an effective response. A range of in-vitro and in-vivo data supports this, although potential problems exist that may require concurrent strategies.

References

Jan 2, 1992·Nature·M J Gething, J Sambrook
Jan 1, 1986·Annual Review of Biochemistry·S Lindquist
Jan 1, 1966·Annual Review of Microbiology·G Klein
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·J H HongW H McBride
Nov 1, 1995·International Journal of Radiation Oncology, Biology, Physics·W C DeweyR E Meyn
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Feb 1, 1994·The Journal of Clinical Investigation·M H Barcellos-HoffJ A Weatherbee
Mar 1, 1996·Gynecologic Oncology·A D SantinG A Granger
Sep 1, 1996·Molecular Endocrinology·M H Barcellos-Hoff, T A Dix
Nov 1, 1996·The Journal of Experimental Medicine·M E van den BroekH Hengartner
Jan 1, 1997·Immunologic Research·Y Kawakami, S A Rosenberg
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·A F OchsenbeinR M Zinkernagel
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Nov 5, 1999·Nature Medicine·S GallucciP Matzinger
Jan 15, 2000·Science·E Finkel
Feb 9, 2000·The Journal of Experimental Medicine·R M SteinmanK Inaba
Feb 24, 2000·The Journal of Experimental Medicine·M J SmythD I Godfrey
Mar 30, 2000·International Journal of Cancer. Journal International Du Cancer·B AbdulkarimJ Bourhis
May 3, 2000·British Journal of Haematology·R VereecqueB Quesnel
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·M Leist, M Jäättelä
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ralph Marvin Steinman, Michel C Nussenzweig
Feb 16, 2002·Acta Oncologica·G G Steel
Feb 28, 2002·Trends in Immunology·Sarah G HarrisRichard P Phipps
Mar 22, 2002·The Lancet Oncology·I TammB Dörken
Mar 27, 2002·Nature Reviews. Immunology·Pramod Srivastava
Jul 18, 2002·The Journal of Experimental Medicine·Kevin L LeggeHabib Zaghouani
Oct 3, 2002·European Journal of Immunology·Rolf M Zinkernagel
Oct 2, 2002·Immunity·Yves DelnestePascale Jeannin
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Stephan R SchefferTim F Greten
Dec 24, 2002·Current Opinion in Immunology·Shizuo Akira

❮ Previous
Next ❯

Citations

Mar 4, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuru MengRalph R Weichselbaum
Jul 5, 2008·Journal of Immunotherapy·Paul HatfieldAlan A Melcher
Feb 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan D SchoenfeldLorelei A Mucci
Feb 12, 2014·Journal of Immunotoxicology·Lorenz KulzerUdo S Gaipl
Dec 1, 2006·Veterinary and Comparative Oncology·D H Thamm
Dec 8, 2006·Radiation Research·Roxana G BalunaCharles R Thomas
Jul 9, 2014·Radiation Research·Molykutty J AryankalayilC Norman Coleman
Aug 24, 2011·Human Vaccines·Jonathan D Schoenfeld, Glenn Dranoff
Aug 30, 2014·The International Journal of Biochemistry & Cell Biology·Baofeng WangHongbing Ma
Sep 26, 2006·International Journal of Cancer. Journal International Du Cancer·Annalisa CapobiancoAngelo A Manfredi
May 11, 2011·Expert Review of Anticancer Therapy·Abdullah FarooqueBilikere S Dwarakanath
Nov 5, 2020·International Journal of Molecular Sciences·Sharda KumariAroumougame Asaithamby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.